Lumentum stock price: $29 million insider sales surface ahead of Tuesday reopen

Lumentum stock price: $29 million insider sales surface ahead of Tuesday reopen

February 16, 2026

New York, Feb 16, 2026, 17:19 (ET) — Markets are done for the day.

  • Lumentum dropped 3.6%, ending Friday’s session at $562.74.
  • EVP Vincent Retort and director Penny Herscher unloaded shares on Feb. 12, according to SEC filings.
  • Midweek brings the Fed minutes into focus for traders, while a series of Lumentum investor events line up later this month.

Lumentum Holdings Inc (LITE.O) insiders have been selling, drawing attention as U.S. markets get back to work on Tuesday after the long weekend. Shares finished Friday’s session at $562.74, down 3.6%. Roughly 5 million shares changed hands that day. U.S. exchanges closed Monday for Washington’s Birthday.

After a surge that drove the stock near its latest highs and drew in quick-moving cash, the forms showed up. Markets are closed Monday, so the next real test will be Tuesday’s open.

Profit-taking could be in play, and traders are also eyeing any ripple from rates before the Federal Reserve’s meeting minutes hit later this week. Lumentum, which makes optical hardware for data centers and telecom networks, operates in a segment that’s seen some dramatic swings.

Executive Vice President Vincent Retort unloaded 45,026 shares on Feb. 12, according to a Form 4, executing multiple open-market sales at prices between $575.795 and $602.185. After the transactions, Retort still holds 102,455 shares. The disclosure noted these trades came under a Rule 10b5-1 plan that was put in place Nov. 13.

Director Penny Herscher offloaded 4,000 shares on Feb. 12, making eight trades at prices between $594.42 and $602.63, according to a Form 4 filing. After the transactions, she listed 2,057 shares held directly and another 39,378 shares held in a living trust.

Lumentum surged to an intraday high of $603.83 on Feb. 12, marking a roughly 74% jump from where shares settled on Jan. 16, according to daily pricing. Since Feb. 3, the stock is up around 29%.

Lumentum turned in $665.5 million in revenue for the quarter on Feb. 3 and projected third-quarter sales of $780 million to $830 million. CEO Michael Hurlston pointed to optical circuit switches—key for directing light signals within data centers—as the main factor behind a backlog now topping $400 million. He also mentioned a fresh “multi-hundred-million-dollar” order for co-packaged optics, set to be shipped in the first half of 2027. Nasdaq

Susquehanna’s Christopher Rolland called it “dramatically better guidance” and pointed to a “step-change” in margins, reacting in a note following the earnings. Investors

There’s a packed midweek ahead for markets. The Federal Reserve’s minutes—always out three weeks after its meetings—are set for release Wednesday, thanks to the Jan. 27-28 policy session.

The stock’s run-up doesn’t leave much cushion if customers slow down ramping orders, and timing on the newer programs could still slip. These optics names are usually the first to feel it if the market turns rocky or data-center spending even hints at a pause.

Lumentum execs are set to appear at Susquehanna’s tech conference on Feb. 26, then again for Morgan Stanley’s Technology, Media & Telecom event on March 2, where a webcast will go live at 11:30 a.m. Pacific. There’s also an investor briefing lined up for March 17 during OFC in Los Angeles.

Marcin Frąckiewicz

Marcin Frąckiewicz is the CEO of TS2 Space and a longtime technology entrepreneur focused on telecommunications, satellite communications and digital innovation. A graduate of the Warsaw School of Economics (SGH), he writes about space technology, artificial intelligence and publicly traded technology companies. His analysis covers major market trends, emerging technologies and the businesses shaping the future of the global economy.

Stock Market Today

  • Skin Elements clinches NZ distribution deal for ECO-Nurture crop spray
    July 8, 2026, 10:53 PM EDT. Skin Elements (ASX: SKN) signed an exclusive deal with Farmlands Co-operative Society in New Zealand to distribute its ECO-Nurture bio-stimulant, focusing on the kiwi fruit segment. Farmlands is starting with a 4,000-litre order worth around $495,000, hoping to tackle PSA, a bacteria that has hit orchards since 2010. ECO-Nurture is a plant-based option to cut chemical use and boost plant health. The target is New Zealand's $4.15 billion kiwifruit industry. Company trials over four seasons with more than 100 orchards turned up positive results. A wider rollout is planned for more crops and markets after regulatory clearance. Farmlands' 80+ stores are expected to push sales growth in the sector.